← Open Payments lookup

STEVEN MILLEN: Open Payments

NPI 1710182209 · ROCKINGHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 32 payments from 13 companies in 2025. Trend: 2023 $726 · 2024 $703 · 2025 $546

Food & beverage: $546
CompanyPaymentsAmount
Lilly USA, LLC11$144
Gilead Sciences, Inc.3$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$60
AstraZeneca Pharmaceuticals LP3$53
Boehringer Ingelheim Pharmaceuticals, Inc.2$38
Novo Nordisk Inc2$36
GlaxoSmithKline, LLC.2$33
Viatris Specialty LLC2$33
Inspire Medical Systems, Inc.1$20
Corcept Therapeutics1$20

Products named: MOUNJARO, JARDIANCE, CAPLYTA, FARXIGA, TRELEGY ELLIPTA, YUPELRI, ZEPBOUND, INSPIRE.

Industry payments across NC — which companies pay providers there.